Your standard cholesterol panel tells you a lot, but not everything. ApoB and Lp(a) are two heart labs that can fill in the gaps, and at Nervana Medical in Sandy, UT we use them to get a clearer picture of long-term cardiovascular risk.

Key Takeaways
- ApoB counts the number of cholesterol-carrying particles that can lodge in artery walls. It can flag risk even when LDL cholesterol looks normal. [1][2]
- Lp(a) is a separate, mostly inherited particle. Diet and exercise barely change it, so most people only need it checked once. [3][4]
- The two tests answer different questions: ApoB tells you how many risky particles you have; Lp(a) tells you whether you carry an extra inherited risk factor.
- At Nervana, we talk about ApoB as under 90 (optimal), 90–129 (a little high), and 130+ (more serious), and Lp(a) as under 75 (optimal), 75–125 (moderate), and over 125 nmol/L (high). These are the ranges we use at Nervana. Our Lp(a) tiers follow the European Atherosclerosis Society’s 2022 consensus, and our ApoB 130 line comes from earlier U.S. guidance (the 2018 AHA/ACC guideline) and the NLA. The 2026 ACC/AHA guideline recommends checking Lp(a) at least once in every adult and treats 125 nmol/L or higher as risk-enhancing. [1][3][4]
- A high number is information, not a diagnosis. It’s a reason for a conversation, not panic.
Why a “normal” cholesterol panel isn’t always the full picture
A standard lipid panel reports LDL cholesterol, the amount of cholesterol carried inside LDL particles. But what actually drives plaque is the particles themselves entering the artery wall. Two people can have the same LDL cholesterol number and very different numbers of particles. [2]
That mismatch, called discordance, is more common in people with insulin resistance, high triglycerides, metabolic syndrome, or type 2 diabetes. In those cases LDL cholesterol can underestimate risk. [2][5]
What is ApoB?
Apolipoprotein B (ApoB) is a protein that sits on every particle capable of causing plaque: LDL, VLDL, IDL, and Lp(a). Each of those particles carries exactly one ApoB molecule, so measuring ApoB is essentially a particle count. [2][5]
The National Lipid Association’s 2024 expert consensus says ApoB can be a useful addition to the standard panel, especially when triglycerides are high, when LDL is already low on treatment, or in people with diabetes or metabolic risk. [2] The 2026 ACC/AHA dyslipidemia guideline says ApoB testing is reasonable in adults already on cholesterol treatment, especially those with atherosclerotic cardiovascular disease, cardiovascular-kidney-metabolic syndrome, type 2 diabetes, or high triglycerides, to help decide whether more treatment is needed once LDL and non-HDL goals are met. [1] European guidelines also recommend ApoB as an alternative risk marker, especially with high triglycerides, diabetes, or obesity. [5]
How we talk about ApoB at Nervana (mg/dL)
| ApoB | What it means | Next step |
|---|---|---|
| Under 90 | Good / optimal | Keep doing what you’re doing |
| 90–129 | A little high | Fix habits, recheck |
| 130+ | More serious | Talk next steps, often medication, not just lifestyle |
How this compares with guidelines: Our 130 mg/dL line comes from the earlier (2018) AHA/ACC guideline and NLA guidance; the 2026 ACC/AHA guideline focuses on ApoB once LDL and non-HDL goals are met. Treatment goals in the European and NLA guidance are often lower than 90 for people who already have heart disease or are at higher risk (for example, under 80, 65, or 55 mg/dL depending on risk level). [2][5] U.S. guidelines also now use LDL-C goals again: under 100 mg/dL for borderline or intermediate risk, under 70 mg/dL for high risk, and under 55 mg/dL for very high-risk atherosclerotic cardiovascular disease, with matching non-HDL goals. [1] Your personal target depends on your whole risk picture, so think of these buckets as a starting point for discussion, not a universal cutoff.
What is Lp(a)?
Lipoprotein(a), pronounced “L-P-little-a,” is an LDL-like particle with an extra protein attached, apolipoprotein(a). Your level is largely set by your genes and stays fairly stable through life. [3][4]
Why it matters: higher Lp(a) is linked to a greater risk of heart attack, stroke, and narrowing of the aortic valve (aortic stenosis), even in people whose other numbers look good. [3][4]
What’s different about Lp(a):
- It’s mostly genetic. Diet, exercise, and weight loss have little effect on it. [3][4]
- Most common cholesterol medicines barely move it. Statins don’t lower it meaningfully. [3][4] Some therapies lower it modestly, and Lp(a)-targeted drugs are being studied in large trials, but none is approved specifically to lower Lp(a) as of this writing. [3][4] For people with atherosclerotic cardiovascular disease and high Lp(a) who are not at their LDL and non-HDL goals on a maximally tolerated statin, the guideline recommends adding a PCSK9 monoclonal antibody that has been shown to reduce cardiovascular events. [1]
- One test is usually enough. The 2026 ACC/AHA guideline now recommends that every adult have Lp(a) measured at least once. [1] Both the European Atherosclerosis Society and the NLA’s 2024 update recommend measuring Lp(a) at least once in adulthood. [3][4]
- It runs in families. The 2026 guideline recommends testing first-degree relatives (parents, siblings, and children) for high Lp(a) when someone has high Lp(a), familial hypercholesterolemia, or premature atherosclerotic cardiovascular disease. [1]
How we talk about Lp(a) at Nervana (nmol/L)
| Lp(a) | What it means |
|---|---|
| Under 75 nmol/L | Optimal |
| 75–125 nmol/L | Moderate risk |
| Over 125 nmol/L | High risk. Talk with your provider |
How this compares with guidelines: These buckets match the European Atherosclerosis Society’s 2022 consensus, which calls under 75 nmol/L “rule out,” 75–125 a “grey zone,” and over 125 “rule in” for added risk. [3] The 2026 ACC/AHA guideline treats 125 nmol/L (50 mg/dL) or higher as risk-enhancing (about 1.4 times the risk), and 250 nmol/L (100 mg/dL) or higher as about double the risk. [1] The NLA’s 2024 update uses roughly 100–125 nmol/L (50 mg/dL) as its risk-enhancing threshold. [4] Risk rises gradually with level rather than switching on at one number. [3]
A note on units
Lp(a) is reported in two ways: nmol/L (particle count, which is preferred) or mg/dL (mass). Quest Diagnostics reports Lp(a) in nmol/L. [6] If your report uses mg/dL, a rough conversion is mg/dL × about 2.0–2.5 ≈ nmol/L. That conversion is approximate only. The size of the particle varies from person to person, and experts advise against relying on a single conversion factor. [3][4] When comparing results over time, use the same units and ideally the same lab.
Why check both together?
- ApoB tells you about your total load of risky particles, which is something you can often change.
- Lp(a) tells you whether you carry an inherited extra risk, which mostly you can’t change.
If your Lp(a) is high, the usual approach is to manage everything else more carefully, including ApoB/LDL, blood pressure, blood sugar, and smoking, because lowering the risks you can change helps offset the one you can’t. [3][4]
Lifestyle that can help ApoB
Lifestyle can meaningfully improve ApoB and LDL for many people. [1][5]
- Cut back on refined carbs and added sugar, especially if your triglycerides are high. [5]
- Limit alcohol, which can raise triglycerides and the particles that carry them. [5]
- Move regularly: aerobic activity plus strength training. [1]
- Swap saturated fat for unsaturated fats, and eat more fiber, like oats, beans, and vegetables. [1][5]
- Address weight and insulin resistance if they’re part of your picture. [2][5]
Be realistic: lifestyle changes may not be enough if ApoB is 130 or higher, if you have a strong family history, or if Lp(a) is high. That’s when a conversation about medication is reasonable. [2]
When to ask Nervana about testing
Consider asking about ApoB and Lp(a) if you:
- Have a family history of early heart attack or stroke (men under 55, women under 65) [1][4]
- Have “normal” LDL but high triglycerides, prediabetes, diabetes, or metabolic syndrome [2]
- Have never had Lp(a) checked [3][4]
- Are working on longevity, hormone, or metabolic health and want a clearer baseline
- Have a relative with known high Lp(a) [3][4]
Ask us which labs fit your situation. Coverage and pricing vary, so we’ll go over that with you.
FAQ
Do I need to fast for ApoB or Lp(a)?
Generally no. Both are reliable without fasting, though your provider may still order a fasting panel for other reasons. [2][3]
If my Lp(a) is normal, do I need to retest?
Usually not. Because it’s mostly genetic, a single test is enough for most adults. [3][4]
My LDL is normal but my ApoB is high. Which one counts?
When they disagree, ApoB more closely tracks particle-driven risk. [2] Talk it through with your provider.
Can supplements lower Lp(a)?
There’s no good evidence that any supplement meaningfully lowers Lp(a). [3]
Is a high number dangerous right now?
These are long-term risk markers, not emergencies. They help us plan prevention.
Want to know your ApoB and Lp(a)?
Book a consult or call (801) 335-5243. Nervana Medical, Sandy, UT.
This article is for education and isn’t a substitute for individual medical advice.
References
- Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. J Am Coll Cardiol. 2026;87(19):2624–2757. https://doi.org/10.1016/j.jacc.2025.11.016
- Soffer DE, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol. 2024. https://doi.org/10.1016/j.jacl.2024.08.013
- Kronenberg F, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925–3946. https://doi.org/10.1093/eurheartj/ehac361
- Koschinsky ML, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024. https://doi.org/10.1016/j.jacl.2024.03.001
- Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111–188. https://doi.org/10.1093/eurheartj/ehz455
- Quest Diagnostics. Lipoprotein (a) test detail (test code 34604). https://testdirectory.questdiagnostics.com/test/test-detail/34604/lipoprotein-a
